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abstract
 
In contrast to skeletal muscle isoforms of myosin binding protein C (MyBP-C), the cardiac isoform
has 11 rather than 10 ﬁbronectin or Ig modules (modules are identiﬁed as C0 to C10, NH
 
2
 
 to COOH terminus), 3
phosphorylation sites between modules C1 and C2, and 28 additional amino acids rich in proline in C5. Phos-
phorylation between C1 and C2 increases maximum Ca-activated force (Fmax), alters thick ﬁlament structure,
and increases the probability of myosin heads on the thick ﬁlament binding to actin on the thin ﬁlament. Unphos-
phorylated C1C2 fragment binds to myosin, but phosphorylation inhibits the binding. MyBP-C also binds to actin.
Using two types of immunoprecipitation and cosedimentation, we show that fragments of MyBP-C containing C0
bind to actin. In low concentrations C0-containing fragments bind to skinned ﬁbers when the NH
 
2
 
 terminus of en-
dogenous MyBP-C is bound to myosin, but not when MyBP-C is bound to actin. C1C2 fragments bind to skinned
ﬁbers when endogenous MyBP-C is bound to actin but not to myosin. Disruption of interactions of endogenous
C0 with a high concentration of added C0C2 fragments produces the same effect on contractility as extraction of
MyBP-C, namely decrease in Fmax and increase in Ca sensitivity. These results suggest that cardiac contractility
can be regulated by shifting the binding of the NH
 
2
 
 terminus of MyBP-C between actin and myosin. This mecha-
nism may have an effect on diastolic ﬁlling of the heart.
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INTRODUCTION
 
Myosin binding protein C (MyBP-C) was ﬁrst discov-
ered in skeletal muscle by Offer et al., (1973), and sub-
sequent work from several laboratories (Craig and Of-
fer, 1976; Starr and Offer, 1978; Koretz, 1979; Bennett
et al., 1986; Davis, 1988; Okagaki et al., 1993; Seiler et
al., 1996; Sebillon et al., 2001) has shown that it can
play an important role in the formation of normal thick
ﬁlaments in striated muscle. In its absence, isolated my-
osin does not form thick ﬁlaments with uniform thick-
ness, uniform length or helically ordered myosin heads
(Koretz, 1979; Lin et al., 1994; Rhee et al., 1994). Un-
der conditions where it may exist as an impurity, more
normally appearing thick ﬁlaments can be made (Maw
and Rowe, 1986). Two to four (most likely three) mole-
cules are distributed every 43 nm within the C zone of
the sarcomere (Craig and Offer, 1976). Three isoforms
of MyBP-C, two skeletal and one cardiac, exist. The car-
diac isoform is found only in cardiac muscle, and the
two skeletal isoforms are not normally expressed in the
heart. The skeletal isoform has 10 modules (labeled
C1-C10) that resemble either ﬁbronectin or immuno-
globulin domains (Gautel et al., 1995; Schwartz et al.,
1995; Gilbert et al., 1996).
Cardiac MyBP-C has two myosin-binding sites. One
site in C10 at the COOH terminus binds to the rod por-
tion of myosin (LMM, Okagaki et al., 1993) and the
other near the NH
 
2
 
 terminus binds to the S2 region of
myosin (Gautel et al., 1995; Gruen and Gautel, 1999;
Gruen et al., 1999). The cardiac isoform differs in three
ways from the two skeletal isoforms (Fig. 1). It has an
extra module at the NH
 
2
 
-terminal (C0), 28 additional
residues in C5, and 3 phosphorylation sites in a se-
quence connecting C1 to C2 (the MyBP-C motif).
Bound to the thick ﬁlament in heart muscle is a Ca-cal-
modulin–regulated kinase that is speciﬁc for these sites
(Hartzell and Glass, 1984; Schlender and Bean, 1991).
Binding of the motif to the S2 region of myosin re-
duces maximum Ca-activated force (Fmax) by 
 
 
 
50%,
but its binding to myosin is markedly decreased by
phosphorylation of these sites. The phosphorylated
C1C2 fragment does not bind to skinned ﬁbers and
does not alter Fmax (Gruen and Gautel, 1999; Kunst et
al., 2000).
The recognition that as much as 40% of familial hy-
pertrophic cardiomyopathy may be due to mutations in
MyBP-C has fostered considerable interest in its func-
tion and the changes in structure and function pro-
duced by its phosphorylation (Bonne et al., 1995; Wat-
kins et al., 1995; Yang et al., 1998; Flavigny et al., 1999).
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Abbreviation used in this paper:
 
 MyBP-C, myosin binding protein C.T
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Cardiac MyBP-C Binding to Actin
 
Although phosphorylation of the protein in reconsti-
tuted contractile systems does not seem to have a major
effect on actomyosin ATPase activity, the degree of
phosphorylation of MyBP-C in intact heart muscle is
changed in the same direction as force development by
the 5 most common modulators of contractility (
 
 
 
 and
 
 
 
 adrenergic agonists, cholinergic transmitters, Ca
 
2
 
 
 
,
endothelin; McClellan et al., 1994; Winegrad, 1999). In
skinned ﬁbers partial extraction of MyBP-C produces a
change in Ca sensitivity, in the velocity of shortening
(Hofmann et al., 1991a), and in Fmax (Kulikovskaya et
al., 2003). Phosphorylation is associated with a change
in structure of thick ﬁlament (Weisberg and Winegrad,
1996, 1998) and in the probability of interaction be-
tween isolated thick and thin ﬁlaments (Levine et al.,
2001). These results have led to the hypothesis that the
probability of forming weak interactions between myo-
sin in thick ﬁlaments and actin in thin ﬁlaments can be
regulated by the degree of phosphorylation of MyBP-C
(Levine et al., 2001; McClellan et al., 2001).
Although it has not been possible to produce normal
thick ﬁlaments in vitro without MyBP-C present, in car-
diac MyBP-C knockout mice, sarcomere pattern in the
heart has a normal appearance (Harris et al., 2002).
Nevertheless the hearts of these mice still undergo hy-
pertrophy and have impaired function. The reason for
this apparent discrepancy is not clear, although it may
be due to compensation such as up-regulation of some
other myosin-binding protein during development of
cardiac muscle.
Recently Moolman-Smook et al. (2002) demonstrated
that modules in the COOH-terminal half of the mole-
cule bind to each other, speciﬁcally C5 to C8 and C7 to
C10. Based on these interactions and the data favoring
three molecules of MyBP-C every 43 mm in the C zone,
they proposed a model in which the three molecules
form a collar around the thick ﬁlament. The C5-C10
portions of each of the three molecules interact with
each other and the C0-C4 regions extend in some un-
deﬁned manner from the thick ﬁlament.
MyBP-C also binds to actin (Moos et al., 1978), but
neither the location of the binding site on MyBP-C nor
the effect of this binding on the function of the con-
tractile system has been clearly determined. There is
some indication that MyBP-C binding to actin increases
actomyosin ATPase activity in solution by producing
links between actin and myosin to form aggregates of
the two contractile proteins (Moos et al., 1978). Be-
cause the NH
 
2
 
 terminus of MyBP-C contains three
phosphorylation sites that can regulate force develop-
ment and the COOH terminus may be involved in
forming a collar around the thick ﬁlament, we consid-
ered the possibility that the NH
 
2
 
 terminus also contains
the actin binding site. Phosphorylation between C1
and C2 may regulate whether the NH
 
2
 
 terminus binds
to myosin or to actin. We examined the structure of
MyBP-C for sequences in the NH
 
2
 
 terminus that resem-
ble known actin binding sequences and found such a
sequence in the region of C0. The properties and func-
tional consequences of C0 binding to actin are re-
ported here.
 
MATERIALS AND METHODS
 
Measurement of Fmax
 
Trabeculae were isolated from the endocardial surface of the
right ventricle of rats that had been killed according to AAALAC
guidelines. The trabeculae were suspended isometrically at sarco-
mere length of 
 
 
 
2.4 
 
 
 
m at room temperature. They were allowed
to recover in a modiﬁed Krebs’ solution (Lin et al., 1991) con-
taining 2.5 mM Ca for 15 min and then bathed in solution of the
same composition containing 2.5 or 1.25 mM Ca for 2 h to pro-
duce two populations of trabeculae with little dephosphorylated
and little phosphorylated MyBP-C. The trabeculae were main-
tained quiescent. The trabeculae then were skinned with Triton
X-100 as previously described (Lin et al., 1991), and the [Ca]-
force relation was determined after the Triton X-100 had been
washed out. Sarcomere length was not controlled during the
contractions. The skinned trabeculae were then soaked in a re-
laxing solution (100 mM KCl, 3 mM EGTA, 7 mM MgCl
 
2
 
, 5 mM
ATP, 15 mM creatine phosphate, and 25 mM imidazole, pH 7.0)
containing one of four fragments of cardiac MyBP-C, either C0,
C0C1, C0C2, or C1C2 at concentrations between 0.3 and 30 
 
 
 
M.
After 30–60 min, a Ca-force curve was determined in solutions
containing MyBP-C fragments. Trabeculae not exposed to a frag-
ment but otherwise treated in the same way served as controls.
After determination of the Ca-tension relation in solution with a
fragment, the muscles were very brieﬂy rinsed with relaxing solu-
tion containing no fragment. The solution was changed to a re-
laxing solution without fragment for different lengths of time
from 5 min to 60 min and then a Ca-force curve was repeated.
Figure 1. Diagram of cardiac MyBP-C showing 11 modules,
binding sites, phosphorylation sites, and regions speciﬁc for the
cardiac isoform. Also shown are the fragments used in this study,
an estimate of their length in numbers of amino acid residues and
the position of the His tag used in preparing the fragments. The
length of a skeletal MyBP-C is  35 nm (Offer et al., 1973).T
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Sarcomere length in the resting trabeculae was not signiﬁcantly al-
tered by the addition of any of the fragments. All solutions were
kept for measurement of the concentration of each fragment by
Western blotting. After determination of the Ca-force relation after
the washout of fragment, the trabeculae were lysed, subjected to
SDS-PAGE, and analyzed by Western blotting for the relative con-
centration of MyBP-C and fragment. Density of bands was quanti-
ﬁed by scanning the gels into NIH Image and measuring the aver-
age density times the area for each band. The amount of protein
added to each lane of the gel was carefully controlled to keep the
densities of bands in the Western blots within the linear range.
 
Expression of Recombinant C0C2
 
The DNA sequence of C0C2 was ampliﬁed by polymerase chain
reaction (PCR), using pMT21-myc-mybpc3 as a template (the
cDNA is human type; Flavigny et al., 1999). Primers were de-
signed on C0C2 fragment’s NH
 
2
 
 and COOH termini and in-
cluded BamH1 and Sal1 restriction sites respectively. They did
not include the myc tag. Primer 1 was 5
 
 
 
-AAAAGGATCCCCG-
GAGCCGGGTAAGAAGCCGGTC-3
 
 
 
, and Primer 2 was 5
 
 
 
-TAT-
AGTCGACTTAGGGCTCTTTCACAAAC-3
 
 
 
. In the ﬁrst primer
the codons encoding two prolines (CCT) and glycine (GGG)
were modiﬁed to produce the synonymous codons preferred for
usage in 
 
E. coli
 
 (CCG, GGT). PCR was performed in a 50 
 
 
 
l mix-
ture using the standard program of the Expand High Fidelity
PCR System (Roche Molecular Biochemicals) and an Eppendorf
Mastercycler. The reaction mixture contained 3 units of Expand
High Fidelity (Expand HF) thermostable polymerase enzyme
mix, 50 ng template plasmid DNA, 50 pmol of each primer, and
200 
 
 
 
M each of dNTP in the supplied Expand HF buffer. Ampli-
ﬁcation parameters were an initial 2 min at 94
 
 
 
C, followed by 25
cycles of 30 s at 94
 
 
 
C, 1 min annealing at 56
 
 
 
C, and 1 min elonga-
tion at 72
 
 
 
C. The PCR product was puriﬁed with a QIAquick PCR
Puriﬁcation Kit (QIAGEN), cut with restriction endonucleases
Bam H1 and Sal 1, run on agarose gel and ﬁnally puriﬁed from
the gel using the QIAquick Gel extraction kit (QIAGEN).
For expression of proteins, Plasmid pQE-80L, containing 6 his-
tidines on the NH
 
2
 
 terminus (QIAGEN), was cut with restriction
endonucleases BamH1 and Sal 1, cleaned with a QIAquick Nu-
cleotide removal kit (QIAGEN), dephosphorylated with calf in-
testinal alkaline phosphatase (Promega, Madison, WI) and ﬁ-
nally puriﬁed from an agarose gel using QIAquick Gel Extraction
Kit (QIAGEN). Ligation of the plasmid and PCR product insert
was performed using the Rapid DNA Ligation Kit (Roche Molec-
ular Biochemicals). 50 
 
 
 
L of BL21-Star chemically competent
cells (QIAGEN) were transformed with the ligation mixture fol-
lowing a standard protocol (20 min on ice, 40 s at 42
 
 
 
C, 3 min re-
covery on ice, dilution with 5,000 
 
 
 
l of S.O.C. media [Invitrogen:
2% trypton, 0.5% yeast extract, 10 mM NaCl, 2 ml 1 N NaOH, 10
mM MgCl
 
2
 
, 2.5 mM KCl, 10 mM MgSO
 
4
 
, 20 mM glucose, pH
7.0], and a 60-min incubation in 37
 
 
 
C shaker). The transformed
cells were plated onto a LB/ampicillin/kanamycin plate and in-
cubated at 37
 
 
 
C overnight.
Several colonies were picked up and grown in LB/ampicillin/
kanamycin media for DNA sequencing and analysis of protein
expression. Automated cycle sequencing was performed by the
University of Pennsylvania DNA sequencing facility. The se-
quence was analyzed to corroborate its accuracy. The sequencing
primer was designed for the promoter area of pQE-80L plasmid.
After selection of the appropriate clone, the cells were grown in
1 liter of medium to an optical density of 0.7–0.8 at 600 nm, and
expression of recombinant His-tagged C0C2 was induced with 1
mM IPTG (Isopropyl-D-thiogalactopyranoside; Roche Molecular
Biochemicals) for 4 h at 37
 
 
 
C or overnight at 30
 
 
 
C and then cen-
trifuged at 4
 
 
 
C for 30 min at 3,000 rpm.
For most preparations a nondenaturing protocol that in-
cluded no denaturing agents was used. Cells, collected by centrif-
ugation, were lysed in 50 ml of B-PER bacterial protein extrac-
tion reagent (Pierce Chemical Co.), with the addition of 0.3 M
NaCl, 5 mM 2-mercaptoethanol and “complete, EDTA-free” pro-
tease inhibitor cocktail tablets (Roche Molecular Biochemicals).
Lysates were sonicated with three 30-s bursts on a Branson Soni-
ﬁer 450 (Branson Ultrasonics) and clariﬁed by spinning at
20,000 rpm for 15 min
For the ﬁrst metal afﬁnity puriﬁcation, 5 ml Ni-NTA resin
(QIAGEN) was equilibrated in “binding buffer,” containing 25
mM phosphate, 20 mM Tris-Cl, 10% glycerol, 0.3 M KCl, 5 mM
2-mercaptoethanol, and 0.5% Triton X-100, pH 8.0. Prepared Ni-
NTA resin was mixed with clariﬁed cell lysate for 1 h at room
temperature, formed into a column, and washed with 500 ml of
“washing buffer” consisting of 25 mM phosphate, 20 mM Tris-Cl,
20 mM imidazole, 10% glycerol, 0.3 M KCl, 5 mM 2-mercaptoeth-
anol, and 0.5% Triton X-100, pH 6.0. Puriﬁed C0C2 fragment
was eluted with the same buffer to which imidazole had been
added to a ﬁnal concentration of 220 mM. Elution fractions were
pooled together and dialyzed overnight against 20 mM Tris-Cl,
100 mM KCl, 5 mM 2-mercaptoethanol, and 0.25% Triton X-100,
pH 7.0.
For the second metal afﬁnity puriﬁcation, 5 ml of TALON
resin (CLONTECH Laboratories, Inc.) was equilibrated with the
same buffer, mixed with dialyzed C0C2 for 15 min at room tem-
perature, formed into a column, washed with 50 ml of the same
buffer, and eluted with relaxing solution containing 5 mM 2-mer-
captoethanol, no EGTA, and 25 mM imidazole, which is sufﬁ-
cient to elute the fragment.
With a second protocol, employed in a minority of prepara-
tions to examine the effect of denaturation and subsequent rena-
turation, urea was used for elution and then removed. Cells, col-
lected by centrifugation, were lysed under denaturing conditions
in Buffer 1: 8 M urea/100 mM sodium phosphate/10 mM Tris Cl,
pH 8.0. Further puriﬁcation on Ni-NTA resin was performed ac-
cording to QIAGEN protocols. The lysate was clariﬁed by centrif-
ugation at 30,000 
 
g
 
 for 20 min, and the supernatant was added to
a 50% slurry of the Ni-NTA agarose (QIAGEN) in the above
buffer at the estimated ratio of 5 mg of protein per 1 ml of resin.
It was then mixed for 1 h. The mixture was loaded into a column
and washed with the above buffer containing 25 mM imidazole
(
 
 
 
10 column volumes). Renaturation of the peptide was accom-
plished by removing urea with washing of the column with Buffer
2: 50 mM sodium phosphate, 300 mM NaCl, 25 mM imidazole,
pH 8.0 (
 
 
 
10 column volumes). Bound recombinant fragment
was eluted from the column with the imidazole gradient from 50
to 500 mM in the Buffer 2. Fractions were analyzed by SDS PAGE
electrophoresis, and the purest fractions were pooled and run
through the D-salt polyacrylamide desalting column (Pierce
Chemical Co.) in order to exchange the buffer into the relaxing
solution. This step also served as the second puriﬁcation step.
The fractions were analyzed by SDS-PAGE and the purest C0C2
was used in the experiments measuring force.
The purity of each fragment preparation was checked by ex-
amining them with SDS PAGE followed by Coomassie blue stain-
ing to detect the presence of other peptides and by Western blot-
ting using antibodies speciﬁc for C0C1 to conﬁrm the identity of
the peptide (Fig. 2). The results show a single band for each frag-
ment on both types of gels. Each fragment migrated with an ap-
parent molecular weight that agreed with the predicted value.
C0C2 on a gel was also identiﬁed by a two antibody technique.
The primary antibody was His-probe (His-15), rabbit polyclonal
IgG (Santa Cruz Biotechnology, Inc.). The secondary antibody was
anti-rabbit IgG-peroxidase (Boehringer). The colorimetric en-
zyme substrate was 1-step TMB-Blotting, (Pierce Chemical Co.).T
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Expression of Recombinant C0 and C1C2 Fragments
 
The cDNA sequence of C0 fragment was ampliﬁed by PCR, using
pMT21-myc-mybpc3 (Flavigny et al., 1999) as a template. Primers
were designed on C0 fragment’s NH
 
2
 
 and COOH termini and in-
cluded BamH1 and SalI restriction sites, respectively. The myc se-
quence was not included in the primer.
Primer 1 was 5
 
 
 
-AAAAGGATCCCCGGAGCCGGGTAAGAAGC-
CGGTC-3
 
 
 
, and Primer 2 was 5
 
 
 
-AAAAGTCGACTTAGTCAT-
CGGGGGCT-3
 
 
 
. PCR was performed in a 50-
 
 
 
l mixture using an
Expand (HF) PCR System (Roche Molecular Biochemicals) and
an Eppendorf Mastercycler. The reaction mixture contained
3 U of Expand High Fidelity thermostable polymerase enzyme
mix, 50 ng template plasmid DNA, 50 pmol of each primer, 200
 
 
 
l each dNTP in supplied Expand HF buffer. Ampliﬁcation pa-
rameters were an initial 2 min at 94
 
 
 
C, followed by 25 cycles of
30 s at 94
 
 
 
C, 1 min annealing at 56
 
 
 
C, and 1 min elongation at
72
 
 
 
C.
The PCR product was puriﬁed with QIAquick PCR Puriﬁca-
tion Kit (QIAGEN), cut with restriction endonucleases Bam H1
and Hind III, electrophoresed on agarose gel and ﬁnally puriﬁed
from the gel using QIAquick Gel Extraction Kit (QIAGEN). For
expression of proteins, plasmid pQE-80L containing six his-
tidines on NH
 
2
 
 terminus (QIAGEN), was cut with restriction en-
donucleases BamH1 and SalI, cleaned with QIAquick Nucleotide
Removal kit (QIAGEN), dephosphorylated with calf intestinal al-
kaline phosphatase (Promega), and ﬁnally puriﬁed from agarose
gel using a QIAquick Gel Extraction Kit (QIAGEN). Ligation of
the plasmid and PCR product insert was performed using Rapid
DNA Ligation Kit (Roche Molecular Biochemicals) according to
instructions.
100 
 
 
 
l of M-15 (pREP 4) chemically competent cells (QIA-
GEN) were transformed with the ligation mixture following a
standard protocol (20 min on ice, 90 s at 42
 
 
 
C heat shock, 3 min
recovery on ice, dilution with 500 
 
 
 
l of S.O.C. media, 45–60 min
incubation in 37
 
 
 
C shaker). The transformed cells were plated
onto a LB/ampicillin/kanamycin plate and incubated at 37
 
 
 
C
overnight.
Several colonies were picked up and grown in LB/ampicillin/
kanamycin media for DNA sequencing and analysis of protein
expression. Automated cycle sequencing was performed by the
University of Pennsylvania DNA sequencing facility. The sequenc-
ing primer was designed for the promoter area of pQE-80L plas-
mid. After selecting the appropriate clone, the cells were grown
in one liter medium to an optical density of 0.7–0.8 at 600 nm
and expression of recombinant His-tagged C0 was induced with 1
mM IPTG (Isopropyl-D-thiogalactopyranoside; Roche Molecular
Biochemicals) for 4 h at 37
 
 
 
C or overnight at 30
 
 
 
C and then cen-
trifuged at 4
 
 
 
C for 30 min at 3,000 rpm.
Cells, collected by centrifugation, were lysed in Buffer 1 (lysis
buffer): 50 mM NaH
 
2
 
PO
 
4
 
, 0.3 M NaCl, 10 mM imidazole, com-
plete protease inhibitors (Roche Molecular Biochemicals) at pH
8.0. The lysate was sonicated three times for 30 s each time and
spun at 20,000 for 15 min. The column was then washed with
Buffer 2: 50 mM NaH
 
2
 
PO
 
4
 
, 0.3 M NaCl, 25 mM imidazole at pH
6.0. Bound and washed recombinant C0 fragment were eluted
from the column with an imidazole gradient from 50 to 500 mM
in the Buffer 2. Fractions were analyzed by SDS-PAGE electro-
phoresis with Coomassie blue staining and Western blotting with
an antibody against C0C1. The purest fractions were pooled
and run through the D-Salt Polyacrylamide Desalting Column
(Pierce Chemical Co.). This step also served as the second puriﬁ-
cation step. Fractions were again analyzed by SDS-PAGE, and the
purest C0, at least 98% C0 as determined by SDS-PAGE, was used
for further experiments (Fig. 2). The ﬁnal buffer was relaxing so-
lution with or without 2-mercaptoethanol.
C1C2 was prepared similarly with NH
 
2
 
 terminus primer: 5
 
 
 
-
TATAGGATCCCCGATTGGCCTCTTC-3
 
 
 
, containing BamHI re-
striction site (underlined) and COOH terminus primer: 5
 
 
 
-TAT-
AGTCGACTTAGGGCTCTTTCACAAAC-3
 
 
 
, containing SalI re-
striction site (underlined).
Gifts of C0C1 and C1C2 were given by Dr. Mathias Gautel
(King’s College, London, UK). The purity of both fragments was
checked as described above (Fig. 2).
 
Preparation of Filamentous Actin
 
Lyophilized monomeric actin (#A2522; Sigma-Aldrich, or Cyto-
skeleton, both from rabbit muscle) was polymerized for 1 h at
room temperature in 5 mM Tris-Cl, 50 mM KCl, 5 mM 2-mercap-
toethanol, 2 mM MgCl
 
2
 
, and 1 mM ATP. The ﬁlamentous actin
stock solution (23 
 
 
 
M) was brieﬂy stored at 4
 
 
 
C. The condition
of the actin was evaluated by SDS-PAGE with Coomassie blue
staining, Western blotting with antiactin, sedimentation after
Figure 2. Gels of puriﬁed fragments
and actin stained with Coomassie blue
after SDS PAGE. (A) successive frac-
tions of C0 during elution; standards at
right. (B) Successive fractions of C0C2
during elution; standards at left. (C)
C1C2 and C0C1; lane 1 contains mark-
ers and (D) actin.T
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high speed centrifugation, binding to 
 
 
 
 actinin, and failure to
bind to bovine serum albumin as measured by cosedimentation.
 
Immunoprecipitation of Actin–Fragment Complex
 
5 nM of a given fragment (either C0, C0C1, C0C2, or C1C2) dis-
solved in 10 
 
 
 
l of relaxing solution were divided into two ali-
quots. With fragment C0C2 and C1C2 one aliquot was treated
with protein kinase A to phosphorylate the fragment and the
other was left completely unphosphorylated. The fragments had
a concentration of 5 
 
 
 
M after this step. Ten micrograms of ﬁla-
mentous actin in 10 
 
 
 
l of PBS (137 mM NaCl, 2.7 mM KCl, 4.3
mM Na
 
2
 
HPO
 
4
 
 and 1.4 mM KH
 
2
 
PO
 
4
 
) was added to the fragment
solution to make an approximately equal concentration of actin
and fragment. The mixture was incubated on a shaker for 2 h at
room temperature. At the end of this incubation the mixture was
divided in two equal volumes for pulldown with anti-actin aga-
rose (see G) or Ni-NTA resin (QIAGEN) that binds to the His-tag
(see above). All experiments were performed at room tempera-
ture in duplicate.
 
Ni-NTA Pulldown of the Actin–Fragment Complexes
 
10 
 
 
 
l of Ni-NTA resin and 40 
 
 
 
l PBS at pH 8.0 were added to half
of each sample (30 
 
 
 
l), containing 
 
 
 
5 
 
 
 
g of a fragment and 5 
 
 
 
g
of actin. The mixture was incubated on a shaker at room temper-
ature for 2 h or at 4
 
 
 
C overnight (results were the same for the
two protocols). Ni-NTA resin with bound protein and peptide
was placed in micro-spin columns (Pierce) and washed exten-
sively with PBS at pH 8. After washing, the protein bound to the
resin was eluted with 20 
 
 
 
l SDS sample buffer, separated on the
4–12% NuPage SDS gel (Invitrogen) and blotted onto PVDF
membrane (Millipore). Western Blot was performed using West-
ern Breeze Kit (Invitrogen), according to instructions. The pri-
mary antibody was rabbit anti-actin (#A 2066; Sigma-Aldrich).
The presence of actin was measured by Western blots using an
antibody against actin. The fragments of MyBP-C were detected
with antibodies to C0C1 and C2C5 to conﬁrm the identity of the
fragments.
 
Pulldown with Antiactin Agarose
 
20 
 
 
 
l of a 50% slurry of agarose coated with goat antiactin IgG
(Santa Cruz Biotechnology, Inc.) were added to the mixture of
MyBP-C fragment and actin and also to two control samples that
did not contain actin. The mixtures were incubated on a shaker
at room temperature for 2 h. Samples were washed in the mi-
crospin columns, and the bound protein and peptide eluted with
SDS sample buffer. The proteins in the eluate were separated on
4–12% NuPage SDS gel and blotted onto PVDF membrane. A
Western Breeze Kit was used according to instructions, and anti-
C0C1 custom-made rabbit antibodies were used as the primary.
 
Cosedimentation of Actin with C0
 
Cosedimentation of fragments of MyBP-C and actin was per-
formed using the Actin Binding Protein Biochem kit (Cytoskele-
ton), Beckman TL-100 ultracentrifuge, and TLS-55 swinging
bucket rotor with adaptors for Ultraclear 200 
 
 
 
l tubes. Each frag-
ment was prepared in the actin compatible buffer (5 mM Tris-Cl,
50 mM KCl, 5 mM 2-mercaptoethanol, pH 7.0) at the highest
possible concentration and centrifuged at 150,000 
 
g
 
 for 1.5 h.
The supernatant was used in subsequent cosedimentation assays.
To form a tighter pellet during centrifugation, 50 
 
 
 
l of “Actin
Cushion Buffer” (5 mM Tris-Cl, 2 mM MgCl
 
2
 
 50 mM KCl 10%
glycerol, pH 8.0) was added to the bottom of each tube. For the
cosedimentation, 40 
 
 
 
l of ﬁlamentous actin stock solution was
mixed with 10 
 
 
 
l of the prepared fragment solution to a ﬁnal
concentration of actin of 4.1 
 
 
 
M. After mixing for 5–30 min at
room temperature (the same temperature at which force mea-
surements were made with skinned ﬁbers) the actin plus frag-
ment was centrifuged at 150,000 
 
g
 
 for 1.5 h. After centrifugation,
aliquots of the supernatant and the pellet were separately ana-
lyzed by SDS-PAGE with Coomassie blue staining.
The extent of interaction between the fragments and actin was
estimated from the absence or the decline in the concentration
of the fragment in the supernatant and the concentration in the
pellet. Relative densities of the bands were measured by densito-
metry using the NIH Image program. In conjunction with the
measurement of fragment binding to actin, the condition of the
actin was checked by its ability to bind 
 
 
 
 actinin and the absence
of binding to bovine serum albumin. Failure to meet these condi-
tions resulted in rejection of the experiment.
 
Phosphorylation of C1C2 and C0C2 Fragments
 
Five nanomoles of each fragment were incubated overnight at
30
 
 
 
C in a total volume of 100  l, containing: 50 mM Tris-Cl, 2.5
mM MgCl2, 1  M cAMP, 1 mM ATP, 0.1 mM CaCl2, 1 mM DTT,
pH 7.5. Phosphorylated fragments were produced by including
25 units of 3 :5 -cyclic AMP–dependent protein kinase, (#P5511;
Sigma-Aldrich). A control consisted of kinase without cAMP in
the medium. Phosphorylation was measured by IEF gels and
Western blotting as previously described in detail (McClellan et
al., 2001). Incubation with kinase resulted in a change from total
unphosphorylation to  85% phosphorylation.
Sample Preparation for SDS-PAGE of Lysates
For electrophoresis of skinned ﬁbers, the NuPAGE Bis-Tris Gel
System (Invitrogen) was used, including precast gradient gels,
MES-SDS running buffer, NuPAGE-LDS sample buffer, NuPage
reducing agent, and NuPage antioxidant. Prior to electrophore-
sis, tissue samples were lysed in Tissue-PELB lysis buffer (Ge-
noTechnology) with addition of complete protease inhibitor
cocktail (Roche Molecular Biochemicals), okadaic acid (Life
Technologies), and kinase inhibitors (Sigma-Aldrich). The total
protein concentration in lysates was measured using Coomassie
plus protein assay (Pierce Chemical Co.). Approximately 30  g
total protein was loaded on each lane of the gel. Prior to electro-
phoresis, washout samples were concentrated generally from 500
 l to 50  l, using ultrafree 0.5 centrifugal ﬁlter device, 10 K
NMWL (Millipore Corp.). The ﬁlter was carefully cleared of all
protein after the concentration procedure (McClellan et al.,
2001).
Western Blotting
These were performed as already described (McClellan et al.,
2001). The relative amounts of MyBP-C and its fragments were
estimated from the relative densities of the bands on Western
blots after reaction with a polyclonal antibody against C0C1 or
C2C5. The concentration of protein applied to each lane and the
exposure time of the blots were chosen to produce bands with
densities linearly related to the amount of protein. The efﬁciency
of transfer of MyBP-C and of the fragments were compared by
measuring several known amounts of each and comparing the
densities produced on the gels. The efﬁciency was the same for
MyBP-C and all the fragments. The density and the area of each
band were measured with the NIH Image program. Although
there are limitations in comparing densities produced by the dif-
ferent peptides or MyBP-C, comparison of density of bands on
the same gel produced by the same peptide is valid as long as the
densities are kept within the linear range of the relation between
amount of peptide and density (McClellan et al., 2001).T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
G
e
n
e
r
a
l
 
P
h
y
s
i
o
l
o
g
y
766 Cardiac MyBP-C Binding to Actin
Statistics
Populations were compared using ANOVA, chi square, regres-
sion analysis, and Student’s t test. Differences were considered
signiﬁcant when P   0.05. When multiple use was made of the
same data, the Bonferroni correction was applied.
RESULTS
Binding of C0-containing Fragments to Actin
Binding of C0-containing fragments of MyBP-C to ﬁla-
mentous actin was examined using three different as-
says: Ni-NTA resin, which binds His-tagged peptides,
antiactin-labeled agarose to pull down actin, and cosed-
imentation to pull down ﬁlamentous actin with frag-
ments that bind to actin. In the ﬁrst two, the extent of
the interaction between ﬁlamentous actin and the frag-
ment was determined by analysis of the material eluted
from the resin or the agarose. In the cosedimentation
assay the extent of binding was determined from the
concentration of fragments in the supernatant and in
the pellet after centrifugation of a solution with a mix-
ture of ﬁlamentous actin and fragment. Binding of
fragments containing C0 occurred with each of the
three methods. Removal of the His-tag with protease
did not alter the binding.
In the immunoprecipitation assays, 0.5–5.0- M frag-
ments of MyBP-C consisting of C0, C0C1, C0C2, or
C1C2 were mixed with 1–5  M actin. After centrifuga-
tion to separate the resin or the agarose, the superna-
tant was retained for Western blot analysis and the resin
or agarose was washed three times with relaxing solu-
tion or PBS. SDS was used to elute the protein bound
to the resin and the agarose. The presence of actin and
fragment in the eluant was conﬁrmed by Western blot-
ting with an antibody against actin or C0C1 (Fig. 3).
In 16 different experiments both immunoprecipita-
tion methods produced binding of fragments of MyBP-C
to actin when the fragments contained C0. C1C2 did
not bind to actin with either of the two protocols. The
presence of the C0 module in the fragment was neces-
sary for the fragment to bind to actin. Phosphorylation
of the C1-C2 linker (MyBP-C motif) in C1C2 or C0C2
did not alter actin binding (Fig. 3). Denaturation of
C0, C0C1, and C0C2 with SDS or urea prevented their
binding to actin. Renaturation by removal of urea only
partially restored binding (Fig. 3). Actin was bound to
C0 less tightly than to C0C1 or C0C2 in as much as
washing several times with relaxing solution removed
some of the C0 bound to actin, but did not signiﬁcantly
reduce the amount of C0C1 or C0C2 bound. This prop-
erty appears to be similar to the binding of the COOH
terminus of MyBP-C to light meromyosin (LMM),
which is stronger when C8 and C9 are included in the
fragment even though the binding site is on C10 (Oka-
gaki et al., 1993).
An estimate of the half-maximum value for the bind-
ing of actin to C0 was derived from the immunoprecip-
itation results in the following way. The initial concen-
trations of actin and the fragment were measured spec-
troscopically, and the threshold amounts of actin and
C0-containing fragments for visibility on Western blots
were determined. Since neither C0-containing frag-
ments nor actin was detected in the supernatant and
the ﬁnal wash solutions, each was assumed to be
present in less than threshold amounts. From these val-
ues an estimate of the concentration that gives half-
maximum binding was  10 5 M.
The binding of C0 and C0C2 to actin was also exam-
ined by cosedimentation using four different concen-
trations of the fragment: 0.1, 0.3, 0.6, and 0.9  M with
4.1  M actin (Fig. 4). After centrifugation of solutions
containing 0.1, 0.3, or 0.6  M C0C2 and ﬁlamentous
actin, no fragment was detected in the supernatant, but
a small amount remained in the supernatant with 0.9-
Figure 3. (A) Western blot with an an-
tibody to cardiac C0C1 showing binding
of actin to C0C2 measured by immu-
noprecipitation (See materials and
methods). Lanes 1 and 2 show results
with a mixture containing C0C2 and ac-
tin. Lane 3 contains only actin, and
lanes 4 and 5 contain C1C2 and actin.
In lanes 2 and 5 the fragments had been
phosphorylated before incubation with
actin. Labels mark expected positions of
C0C2 and C1C2. (B) A Western blot
with antiactin showing the binding of
actin to natural C0 (lane 2) and natural
C0C2 (no exposure to urea, lane 5), but
the absence after denaturation with
urea (C0, lane 1) and decrease (C0C2,
lane 4) after renaturation by removal of
the urea. Lane 3 contains only the resin.
The lane at left contains only actin.T
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 M fragment. From the concentrations of the frag-
ments and actin in the starting solution, in the superna-
tant and in the pellet, the relative amounts of the frag-
ment and actin interacting were calculated. The stoi-
chiometry of fragment to actin in the pellet with 0.6
and 0.9  M C0C2 was not signiﬁcantly different, indi-
cating that at these concentrations actin had been satu-
rated with the fragment. The stoichiometry of frag-
ment to actin was  1:7. C0 was bound less strongly
than C0C2 in this assay too.
Reciprocal Binding of C0C1 and C1C2
To evaluate the relationship between binding of the C0-
containing fragment of MyBP-C to actin and binding of
C1C2 to myosin, two groups of skinned ﬁbers were pre-
pared by soaking cardiac trabeculae in a bathing solu-
tion containing 2.5 or 1.25 mM Ca before they were
skinned. As measured by IEF gels, trabeculae in the
former group contained little completely unphosphor-
ylated MyBP-C (Fig. 5; McClellan et al., 2001). In the
latter group most of the MyBP-C was unphosphory-
lated. Modiﬁcation of phosphorylation of MyBP-C by
variation of the concentration of extracellular Ca be-
fore skinning was used because this method affects the
phosphorylation of only MyBP-C and does not alter
phosphorylation of troponin or the regulatory light
chain of myosin (McClellan et al., 2001). Use of protein
kinase or phosphatase after skinning would have al-
tered phosphorylation of troponin, which would have
complicated the interpretation of the results. All frag-
ments except those containing C1C2 modules and spe-
ciﬁcally incubated with kinase were completely unphos-
phorylated.
Since unphosphorylated MyBP-C binds to the S2 re-
gion of myosin (S2) but phosphorylated MyBP-C does
not (Kunst et al., 2000), distribution of binding of the
NH2 terminus of endogenous MyBP-C between actin
and myosin might vary according to the extent of phos-
phorylation of MyBP-C. Trabeculae from each group
(n   4) were incubated in relaxing solution containing
a low concentration (0.01  M) of either C0C1, C1C2,
or C0C2. A low concentration, equivalent to  3% of
Figure. 4. (Top) Coomassie blue–stained gels after SDS-PAGE in
cosedimentation experiments. Lane 1 contains standards. Lanes 2,
5, and 8 contain the beginning solutions; lanes 3, 6, and 9 the su-
pernatants after centrifugation; and lanes 4, 7, and 10 contain the
pellets. In lanes 2–4 the starting solution contained only ﬁlamen-
tous actin. In lanes 5–7 and 8–10 the starting solutions contained
ﬁlamentous actin and C0C2. The actin concentration in all three
runs was 4.1  M. In lanes 5–7 and 8–10 the concentrations of
C0C2 were, respectively, 0.3 and 0.1  M. (Bottom) Cosedimenta-
tion showing saturation of actin with C0C2. Lanes 1 and 3 are su-
pernatant and lanes 2 and 4 are pellet. Concentrations of C0C2 in
initial solution in lanes 1 and 2 and 3 and 4 are, respectively, 0.6
and 0.9  M. Lane 5 contains markers with values to the right.
Figure 5. (A) IEF gel of lysate of two muscles stained with anti-
C0C1, one soaked at rest in bathing solution containing 2.5 mM
Ca, and a second soaked in a bathing solution of the same compo-
sition except that Ca was 1.25 mM. The different bands indicate
MyBP-C containing 0, 1, 2, and 3 phosphates per molecule of
MyBP-C. (B) The average distribution of phosphorylated forms
of MyBP-C in eight experiments.T
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endogenous protein, was used to avoid signiﬁcant dis-
placement of endogenous MyBP-C from binding sites
on myosin or actin. After 30 min exposure to the frag-
ment, the trabeculae were very brieﬂy washed to re-
move the excess fragment, exposed to SDS, and elec-
trophoresed on polyacrylmide gels. Western blotting
was performed with an antibody against C0C1.
In trabeculae with primarily unphosphorylated
MyBP-C and therefore a high degree of binding of en-
dogenous C1C2 to myosin, C1C2 added to the incuba-
tion medium did not bind to the trabeculae (Fig. 6).
There was, however, a substantial amount of binding of
C0C1. The opposite was observed when the trabeculae
had a high degree of phosphorylation of endogenous
MyBP-C. A substantial amount of C1C2 but no detect-
able C0C1 was bound. C0C2, which contains the bind-
ing sites to both actin and myosin, was bound to trabec-
ulae with little unphosphorylated MyBP-C and to a
lesser degree to trabeculae with primarily unphosphor-
ylated MyBP-C. Phosphorylated C1C2 was not studied
because Gruen and Gautel (1999) have already shown,
and we have conﬁrmed, that phosphorylated C1C2
does not bind to myosin.
These results are consistent with the hypothesis that,
in the presence of unphosphorylated MyBP-C, the
binding site on myosin at the NH2 terminus for C1C2 is
occupied by endogenous MyBP-C, and in the virtual ab-
sence of unphosphorylated MyBP-C, the binding site
for C0C1 on actin is occupied.
Effect of C0 and C0C1 Fragments on Contractility
The effect of C0 on contractility was determined by in-
cubating skinned cardiac trabeculae with 0.3–5.0- M
C0 fragments added to relaxing and then to contrac-
Figure 6. Western blots stained with
anti-C0C1 showing reciprocal binding
of C0C1 and C1C2 by skinned cardiac
muscle occurs depending on the de-
gree of phosphorylation of endogenous
MyBP-C. (Right) The intact cardiac
muscle was soaked in 1.25 mM Ca at
rest for 2 h to produce a low level of
phosphorylation after skinning. (Left)
The intact cardiac muscle was soaked in
2.5 mM Ca at rest for 2 h to produce a
high level of phosphorylation after skin-
ning. Labels at the bottom indicate the
fragment added to the skinned ﬁber
preparation before lysing. Labels to the
right indicate the position of a particu-
lar fragment on the gel. After skinning
muscles were then soaked in relaxing
solution containing a low concentration
of the speciﬁed fragment (0.01  M)
and then brieﬂy washed before lysing and electrophoresis. Note that C0C1 does not bind when phosphorylation is high (2.5 mM Ca). Pre-
sumably endogenous C0 is bound to actin under these conditions. C1C2 does not bind when phosphorylation is low (1.25 mM Ca), and
endogenous C1C2 is bound to myosin. The faint bands present in gels of trabeculae soaked in 1.25 mM Ca are proteolytic fragments of
MyBP-C, which are more common with unphosphorylated MyBP-C.
Figure 7. Force tracing of a cardiac trabecula
that had been skinned after a 2-h exposure to
Krebs’ solution containing 2.5 mM Ca. Note de-
crease in Fmax and increase in force at pCa 5.6 in
presence of 3  M C0. Changes are reversed
within 10–15 min of bathing in a medium without
C0. Calibration bars equal 15 min and 0.05 g.
Thin arrows pointing down indicate pCa of 6.0,
5.6, and 5.2 in that order. Short thick arrows indi-
cate 5.0 and longer thick arrows indicate 4.5.
Short arrows pointing up indicate pCa of 9.0.T
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tion solutions (Fig. 7). The trabeculae had been soaked
in solution containing either 1.25 or 2.5 mM Ca for 2 h
before skinning to vary the degree of phosphorylation
of endogenous MyBP-C (Table I). In the ﬁrst series of
contraction solutions containing pCa 9.0 to 4.5, maxi-
mum Ca activated force (Fmax) for unphosphorylated
skinned ﬁbers was  30% lower than that for phosphor-
ylated ﬁbers (Table I, n   16 for each value; P   0.02;
this has already been shown by McClellan et al., 2001).
There was, however, no signiﬁcant difference in the Ca
sensitivity of ﬁbers associated with the large difference
in phosphorylation of MyBP-C (Fig. 8). (Skinning does
not alter the degree of phosphorylation of MyBP-C; Mc-
Clellan et al., 2001). The solution was then changed to
one containing C0 fragments with pCa of 9.0. 30 min
later the pCa was decreased in steps from 9.0 to 4.5. Af-
ter this series of solutions the trabeculae were again ex-
posed to pCa 9.0 to 4.5 without C0 fragments.
C0 fragments increased Ca sensitivity in both groups
of skinned ﬁbers. With phosphorylated trabeculae, C0
fragments caused an increase in Ca sensitivity at sub-
maximal force that almost completely reversed within
20 min after the fragments had been removed (Figs. 7
and 9). The threshold was 0.8–1.0  M, and the maxi-
mum effect occurred at 3–4  M. The extent of change
in Ca sensitivity was substantially less but equally revers-
ible when the trabeculae had only a low degree of phos-
phorylation of MyBP-C (Fig. 9). The largest increase in
Ca sensitivity occurred with Ca concentrations that nor-
mally produce low levels of force. The result was a dra-
matic increase in force over a small range of Ca con-
centration producing a large value for the Hill coefﬁ-
cient.
During exposure to 3- M C0 fragments, Fmax of
phosphorylated skinned ﬁbers decreased by 15   7%
(n   18) and recovered when the fragments were re-
moved (Fig. 7). The signiﬁcance was borderline with
P   0.06 but  0.05 (Table I). The effect of the more
strongly binding C0C1 on Fmax was unequivocal. With
2  M C0C1, Fmax of phosphorylated skinned ﬁbers de-
creased by 31   8% (n   6, P   0.05). The greater ef-
fect with C0C1 than C0 is consistent with the stronger
binding of C0 when it is present in a fragment with ad-
ditional modules. In trabeculae with primarily unphos-
phorylated MyBP-C there was no signiﬁcant change in
Fmax with the same concentrations of C0C1 that were
effective with phosphorylated MyBP-C.
Dephosphorylation of MyBP-C decreases Fmax in
skinned cardiac ﬁbers by increasing C1C2 binding to
the S2 region of myosin (Kunst et al., 2000). If endoge-
nous C0 binding to actin enhances contractility and
binding of endogenous C1C2 to myosin depresses con-
tractility, then addition of a high enough concentration
of C0-containing fragment to disrupt the interaction
between endogenous C0 with actin should have a sub-
stantially larger effect on the contractility of skinned ﬁ-
bers with the greater phosphorylation of MyBP-C. This
difference was observed (Table I).
Effect of C0C2 on Contractility
The interaction of C0 and C1C2 binding when the two
peptides were present in one protein, as they normally
are, was examined by exposing skinned trabeculae to
C0C2. Fibers with an approximately equal amount of
totally phosphorylated and unphosphorylated MyBP-C
were studied, using a protocol similar to that used for
C0. Contractions with pCa from 9.0 to 4.5 were re-
corded before, during, and after exposure to 2  M
C0C2.
The contractile response was complex (Fig. 10). A
pCa of 6.0 normally produces a small amount of ten-
sion, but in the presence of 2  M C0C2 tension devel-
oped very rapidly to a value close to Fmax. The re-
sponse of the Ca sensitivity resembled that produced by
TABLE I
Effect of C0-containing Fragments of MyBP-C on Contractility
High phosphorylation
of MyBP-C
Low phosphorylation
of MyBP-C
mN/mm2 mN/mm2
Before C0 or C0C2 27.1   1.8 16.6   2.0a
During C0C2 19.6   1.3a 15.9   2.3a
During C0 23.1   1.8 16.1   2.2a
After C0C2 18.7   1.7a 15.3   1.7a
After C0 25.3   1.4 15.8   2.0a
aDifference form high phosphorylation before C0; P   0.05, n   12.
Figure 8. Force/[Ca] relation of trabeculae skinned after 2 h
soak in Krebs’ solution containing either 1.25 mM (ﬁlled circles)
or 2.5 mM (open circles) Ca. There is no signiﬁcant difference.T
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770 Cardiac MyBP-C Binding to Actin
C0. With C0C2, tension quickly began to decay and
dropped by 26   9% (n   8 trabeculae; P   0.01). This
lower value remained after C0C2 had been removed
from the bathing medium in spite of several changes of
solution. At this point the residual content of C0C2 in
the muscle was measured by Western blotting (Fig. 10
B) and compared with the density of a series of calibra-
tion values to provide absolute amounts. 10 nmoles of
C0C2 per g of tissue were present 60–70 min after the
removal of C0C2 from the solution (n   4; P   0.01).
This corresponds to a stoichiometry of  1:15. Such an
effect on contractility from this low level of binding is
not unreasonable in view of the ﬁnding of Moos et al.
(1978) that even one molecule of MyBP-C per 20 actins
can have a major effect on the physical properties of
the ﬁlaments. In contrast, C0 was washed from the mus-
cle with a half-time of  10 min (unpublished data). As
measured by Western blotting no myosin or MyBP-C
was lost from the muscle during this period (unpub-
lished data).
The results can be summarized as an initial rapid
“C0-like” effect on Ca sensitivity followed by a persistent
decrease in Fmax associated with a persistent binding
of C0C2 by the muscle. The decrease in Fmax was prob-
ably due to the combined effects of C0C2 binding to
myosin and actin. The slower washout and longer effect
on contractility of C0C2 are consistent with the stron-
ger binding of C0C2 than C0 found above.
In skinned ﬁbers with a high degree of phosphoryla-
tion of MyBP-C, incubation in a solution containing
C0C2 produced a signiﬁcant decrease in Fmax that did
not reverse during 60 min after the removal of C0C2
(Table I). The threshold concentration for the changes
in contractility was 0.5  M, and maximum effect was
achieved with 3–5  M. C0C2 had no signiﬁcant effect
on Fmax of skinned ﬁbers with a low degree of phos-
phorylation.
DISCUSSION
By decreasing the afﬁnity of C1C2 for myosin S2, phos-
phorylation of MyBP-C in cardiac muscle can modify
the structure of the thick ﬁlament and modulate con-
tractility (Gautel et al., 1995; Weisberg and Winegrad,
1996, 1998; Kunst et al., 2000). The mechanism of the
change appears to involve an alteration in the number
of myosin heads bound to actin in the nonforce gener-
ating, loosely bound state that precedes the entry of the
cross-bridge into the force generating cycle (Levine et
al., 2001; McClellan et al., 2001).
Moos et al. (1978), Hartzell (1985), and Yamamoto
(1986) have shown that skeletal MyBP-C can bind to ac-
tin in the micromolar range. By forming stable actin–
myosin aggregates in solution, MyBP-C binding to actin
stimulates actin activated but not Ca-, Mg-, or EDTA-
activated myosin ATPase activity. In spite of these obser-
vations of skeletal MyBP-C, a role for the MyBP-C inter-
action with actin in the normal function of heart muscle
has not been elucidated. MyBP-C binds strongly to I
bands (Moos, 1981) and, in transfected cardiac myo-
cytes, to a region within the A bands, but C0 does not
bind to myosin in solution (Kunst et al., 2000).
Here we have demonstrated that there is a site on the
C0 module of MyBP-C that binds actin with an afﬁnity
similar to that found for skeletal MyBP-C in myoﬁbrils.
Isolated C0 modules bind to ﬁlamentous actin, but the
afﬁnity of C0 for ﬁlamentous actin and for skinned ﬁbers
is greater when it is present in a larger fragment such as
C0C2. This is apparent in immunoprecipitation and
cosedimentation assays as well as in the magnitude and
the duration of the effect of C0-containing fragments on
Figure 9. Addition of 3- M
C0 fragments to solution
bathing skinned rat cardiac
trabecula increases Ca sensi-
tivity. The effect of C0 was
compared on two different
types of preparations: trabec-
ulae with a high (left) and tra-
beculae with a low (right) de-
gree of phosphorylation of
endogenous MyBP-C. In the
former, C0 of a majority of
MyBP-C are bound to actin,
and in the latter a majority of
C1C2 are bound to myosin.
Force is expressed as percent
of maximum. Open squares
indicate before addition of
C0; x indicates with C0; and
ﬁlled circles indicate after C0
removal.T
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contractility. The binding of C0C2 is still due to the pres-
ence of C0 because in these studies C1C2 did not bind to
actin. The enhancement of binding of the C0 module by
the presence of adjacent modules in the fragment is sim-
ilar to what has been observed with the C terminus bind-
ing to LMM (Okagaki et al., 1993). The binding site is in
C10, but the presence of C8 and C9 increases the afﬁnity.
For this reason the quantitative studies of C0 binding to
actin have been performed with C0C2.
In cardiac muscle, exogenous C0 at a low concentra-
tion that does not alter contractility does not bind to tra-
beculae when the MyBP-C is phosphorylated and endog-
enous C0 is presumably bound to actin. C0 does bind to
actin when MyBP-C is not phosphorylated and is bound
to S2 through its NH2 terminus. This suggests that C0
added at low concentration to skinned cardiac trabecu-
lae binds to the same actin as endogenous C0 in phos-
phorylated MyBP-C even though these actins are only a
small fraction of the total population in the thin ﬁla-
ments. Under these conditions other actin molecules ap-
pear to have a lower afﬁnity for C0 and do not bind C0.
The presence of regulatory proteins in thin ﬁlaments in
skinned ﬁbers could produce heterogeneity of actin
monomers that results in different afﬁnities for MyBP-C,
particularly since one of the subunits of troponin binds
to actin, and tropomyosin can block sites on actin.
C0 binding to ﬁlamentous actin, in which there are
no regulatory proteins, appears to saturate with a stoi-
chiometry of  1:7. Moos et al. (1978) found a similar
stoichiometry of 1:5 using skeletal MyBP-C. This ratio is
quite similar to the periodicity of the regulatory pro-
teins in native thin ﬁlaments and is suggestive that ei-
ther all actin molecules in a thin ﬁlament are not equiv-
alent or the binding of C0 or MyBP-C to an actin mono-
mer decreases the afﬁnity of other monomers in the
same ﬁlament for C0. Moos et al. (1978) came to a sim-
ilar conclusion that the binding of one skeletal MyBP-C
molecule to ﬁlamentous actin blocked the interactions
of up to ﬁve, presumably adjacent, molecules of actin
with MyBP-C. We have also found a similar limit in the
amount of C1C2 bound to skinned ﬁbers. The stoichi-
ometry at saturation is  1:4 (unpublished data).
In higher concentrations, exogenous C0C2 decreases
Fmax but only when MyBP-C is phosphorylated and
bound presumably to actin and not to myosin. At these
concentrations C0 appears to displace endogenous
MyBP-C and disrupt the interaction between endoge-
nous C0 and actin, decreasing development of force.
C0 binding to actin enhances contractility only when it
is part of the intact MyBP-C with its COOH terminus
bound to LMM.
The mechanism of action of MyBP-C and its phos-
phorylation on contractility remains obscure because
MyBP-C is concentrated in only one part of the sarco-
mere and has a low stoichiometry in its interactions
with actin and myosin. Yet fragments of MyBP-C can
modify force by  50% (Kunst et al., 2000). The facts
that phosphorylation of MyBP-C only alters myosin–
actin interaction (ATPase and force) in organized myo-
ﬁbrils and phosphorylation of MyBP-C changes the
structure of the whole ﬁlament argue in favor of a
mechanism in which the overall structure of thick ﬁla-
ments can be modulated by interactions in a limited re-
gion of the ﬁlament (Weisberg and Winegrad, 1996;
Winegrad, 1999; Levine et al., 2001).
When the binding sites on C0 and C1C2 are both
present on the same peptide, the change in contractil-
ity resembles the combination of the effects of the two
separate peptides except that unphosphorylated C0C2
binds with a greater afﬁnity than C1C2 or C0. The
amount of C0C2 bound to skinned ﬁbers was more
when endogenous MyBP-C is phosphorylated and the
C1C2 site was open than when it was dephosphorylated
and the actin site was open. This suggests that the afﬁn-
ity of the C1C2 site for myosin is greater than the afﬁn-
ity of C0 for actin. This interpretation is consistent with
the persistence of the effect on contractility from C0C2
compared with C0.
Figure 10. (A) Force tracing of a skinned car-
diac trabecula before, during, and after soaking
in 2  M C0C2. Calibration lines equal 0.05 g and
20 min. Thin arrows pointing down indicate pCa
of 6.0, 5.6, and 5.2 in that order. Short thick ar-
rows indicate 5.0 and longer thick arrows indicate
4.5. Short arrows pointing up indicate pCa of 9.0.
(B) Western blot of lysate of trabeculae stained
with anti-His tag to demonstrate retention of
C0C2 after 60 min in solutions without C0C2. In
lanes 1 and 2 the trabeculae had been exposed to
C0C2 for 75 min before the 60 min without C0C2.
Lane 3 is the control, in which the 75 min soak so-
lution did not contain C0C2. Lane 4 is C0C2.T
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These results suggest that phosphorylation deter-
mines where the NH2 terminus of MyBP-C binds and
the location of the NH2 terminus, in turn, modulates
contractility through an inﬂuence on the formation of
weak bonds between actin and myosin (Levine et al.,
2001). If this is the case, phosphorylated MyBP-C could
act as a load on the contraction. At ﬁrst thought this
should have an undesirable effect on the development
of force. However, with cardiac muscle (skeletal iso-
forms of MyBP-C do not contain C0 or phosphorylation
sites) such a load could serve a useful function if cardiac
MyBP-C is compliant. Some of the energy generated
during systole would be stored in the compliance to as-
sist in the ﬁlling of the heart during diastole. In the ab-
sence of phosphorylation of the motif between C1 and
C2, C1C2 would bind to myosin, and the compliance of
MyBP-C would not be in parallel with the force genera-
tors and not store energy for release during diastole.
There are four independent observations in the liter-
ature that support such a mechanism. Hofmann et al.
(1991b) observed that partial removal of MyBP-C from
isolated cardiac cells increased maximum velocity of
unloaded shortening (Vmax) at submaximal activation,
an effect they attributed to removal of an internal load.
Harris et al. (2002) observed impairment of diastole in
their MyBP-C knockout preparations of heart. The rate
of relaxation of an isolated heart is also enhanced by
phosphorylation of cardiac MyBP-C (Hartzell, 1984).
Calaghan et al. (2000) have found that excess S2, which
would be expected to bind strongly to endogenous
MyBP-C, slows relaxation. In addition, the rate of dia-
stolic ﬁlling of the ventricles becomes progressively
more important as the heart rate increases, and   ad-
renergic stimulation, which is one of the major mecha-
nisms for increasing heart rate, also increases phos-
phorylation of MyBP-C.
For cardiac MyBP-C to store energy effectively during
systole, it must not detach and reattach to actin during
the contraction because detachment and reattachment
would dissipate as heat the energy stored in the compli-
ance. By analogy with the compliant molecule titin,
cardiac MyBP-C may have sufﬁcient compliance and
length for cardiac MyBP-C to remain attached to the
same actin throughout a contraction. The amino acid
sequence of the proline-rich region of C0 and C1 has a
high level of homology with the compliant PEVK re-
gion of titin (58%, Fig. 11), and cardiac MyBP-C con-
tains tandem Ig domains, the other major source of
compliance in titin (Kellermayer et al., 1998; Trombitas
et al., 1998; Granzier and Labeit, 2002). Under normal
conditions, myocardial cells shorten 150–200 nm per
half-sarcomere during a contraction that ejects  50%
of the ventricular contents. Since cardiac MyBP-C con-
tains  1,300 amino acid residues, its maximum length
should be  1,300   0.37 or 481 nm, but about half
that length (C5–C10) probably forms a “collar” around
the thick ﬁlament (Moolman-Smook et al., 2002), leav-
ing a maximum of  240 nm to connect actin to LMM
during the contraction. This value is almost twice the
required length to maintain attachment to the same ac-
tin, but the force required to extend MyBP-C the neces-
sary 150 nm is not known. The distance between the
surfaces of the thick and thin ﬁlaments is  12–13 nm
(the length of a skeletal MyBP-C is  35 nm; Offer et al.,
1973). Therefore, it is likely that cardiac MyBP-C is
heavily folded in the resting muscle. Although these
calculations demonstrate feasibility, in the absence of
detailed information about the physical properties of
cardiac MyBP-C, the existence of a compliance that
aids diastolic ﬁlling can only be speculative.
Three different interventions should modify endoge-
nous C0 interaction with actin and alter contractility:
(a) disruption of endogenous C0 interaction with actin
by exogenous C0 at a sufﬁcient concentration; (b) ex-
traction of MyBP-C; and (c) incubation with exogenous
C1C2. All three result in similar changes in Fmax and
Ca sensitivity that are dependent on the state of phos-
phorylation of endogenous MyBP-C. All three probably
have the same ﬁnal pathway.
Disruption of C0 interaction with actin in in vitro
preparations modiﬁes Ca sensitivity, but an increase or
a decrease in phosphorylation of MyBP-C in intact cells
Figure 11. Comparison of the amino acid se-
quence of the proline-rich region of C0 with the
sequence of the PEVK region of titin indicates a
high degree of homology (58%).T
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does not change Ca sensitivity or the Hill coefﬁcient.
There is an important difference between decreasing
endogenous C0-actin interactions with added C0 frag-
ments in skinned ﬁbers and decreasing phosphoryla-
tion of MyBP-C in intact cells. In the ﬁrst case, the phos-
phorylated NH2 terminus of endogenous MyBP-C will
not bind to myosin when the endogenous C0 interac-
tion with actin is disrupted by added C0 fragments. In
the second case disruption of the C0–actin interaction
is produced by the dephosphorylation of the motif,
which will allow binding of the NH2 terminus to myosin.
The results of this study indicate that phosphoryla-
tion of the NH2 terminus of MyBP-C determines the
distribution of binding between actin and myosin,
which in turn regulates two properties of the force gen-
erators, the magnitude of a parallel compliance and
the probability of myosin heads entering the force gen-
erating cycle. Through this mechanism, the strength of
developed force, the power of the contraction of the
heart and possibly the rate of diastolic ﬁlling can be var-
ied. Myoﬁbrillar proteins not directly involved in gener-
ating force can regulate cardiac contractility.
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